Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $421.68 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $248.53 | 2 | $0 (2024) |
| BeiGene USA, Inc. | $28.31 | 1 | $0 (2024) |
| ABBVIE INC. | $25.34 | 1 | $0 (2024) |
| PUMA BIOTECHNOLOGY, INC. | $23.71 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $22.55 | 1 | $0 (2024) |
| Tempus AI, Inc | $21.53 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $19.48 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $17.90 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $14.33 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $297.80 | 9 | Merck Sharp & Dohme LLC ($124.65) |
| 2023 | $123.88 | 1 | Merck Sharp & Dohme LLC ($123.88) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $17.90 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $21.53 | General |
| 10/21/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $23.71 | General |
| 10/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.55 | General |
| 08/02/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Food and Beverage | In-kind items and services | $124.65 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Oncology | ||||||
| 03/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Oncology | ||||||
| 03/06/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Oncology | ||||||
| 09/19/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $123.88 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 75 | 104 | $22,782 | $8,704 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 75 | $15,078 | $5,481 | 36.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 29 | $7,704 | $3,223 | 41.8% |
About Dr. Michail Alevizakos, MD
Dr. Michail Alevizakos, MD is a Hematology & Oncology healthcare provider based in Chesapeake, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2017. The National Provider Identifier (NPI) number assigned to this provider is 1588191662.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michail Alevizakos, MD has received a total of $421.68 in payments from pharmaceutical and medical device companies, with $297.80 received in 2024. These payments were reported across 10 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($421.68).
As a Medicare-enrolled provider, Alevizakos has provided services to 75 Medicare beneficiaries, totaling 104 services with total Medicare billing of $8,704. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Chesapeake, VA
- Active Since 05/19/2017
- Last Updated 08/23/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1588191662
Products in Payments
- WELIREG (Drug) $124.65
- KEYTRUDA (Biological) $123.88
- BRUKINSA (Drug) $28.31
- VENCLEXTA (Drug) $25.34
- Xtandi (Drug) $19.48
- KRAZATI (Drug) $17.90
- Nubeqa (Drug) $14.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Chesapeake
William Maclaughlin, Md, MD
Hematology & Oncology — Payments: $4,512
Amy Skorupa, Md, MD
Hematology & Oncology — Payments: $3,783
Craig Franzman, Md, MD
Hematology & Oncology — Payments: $1,917
Cristina Alencar, M.d, M.D
Hematology & Oncology — Payments: $272.82
William Clark, Md, MD
Hematology & Oncology — Payments: $87.50